COVID-19 for the cardiologist: basic virology, epidemiology, cardiac manifestations, and potential therapeutic strategies
Summary Coronavirus disease-2019 (COVID-19), a contagious disease caused by severe
acute respiratory syndrome-coronavirus-2 (SARS-CoV-2), has reached pandemic status. As …
acute respiratory syndrome-coronavirus-2 (SARS-CoV-2), has reached pandemic status. As …
Arrhythmias and COVID-19: a review
P Dherange, J Lang, P Qian, B Oberfeld… - Clinical …, 2020 - jacc.org
Current understanding of the impact of coronavirus disease-2019 (COVID-19) on
arrhythmias continues to evolve as new data emerge. Cardiac arrhythmias are more …
arrhythmias continues to evolve as new data emerge. Cardiac arrhythmias are more …
Seasonal influenza infections and cardiovascular disease mortality
Importance Cardiovascular deaths and influenza epidemics peak during winter in temperate
regions. Objectives To quantify the temporal association between population increases in …
regions. Objectives To quantify the temporal association between population increases in …
A current review of COVID-19 for the cardiovascular specialist
JP Lang, X Wang, FA Moura, HK Siddiqi… - American heart …, 2020 - Elsevier
Abstract Although coronavirus disease 2019 (COVID-19) predominantly disrupts the
respiratory system, there is accumulating experience that the disease, particularly in its more …
respiratory system, there is accumulating experience that the disease, particularly in its more …
[PDF][PDF] COVID-19 for the cardiologist: a current review of the virology, clinical epidemiology, cardiac and other clinical manifestations and potential therapeutic …
Summary The coronavirus disease-2019 (COVID-19), a contagious disease caused by
severe acute respiratory syndrome coronavirus-2 (SARS-CoV2), has reached pandemic …
severe acute respiratory syndrome coronavirus-2 (SARS-CoV2), has reached pandemic …
[HTML][HTML] How close are countries of the WHO European Region to achieving the goal of vaccinating 75% of key risk groups against influenza? Results from national …
P Jorgensen, J Mereckiene, S Cotter, K Johansen… - Vaccine, 2018 - Elsevier
Background Influenza vaccination is recommended especially for persons at risk of
complications. In 2003, the World Health Assembly urged Member States (MS) to increase …
complications. In 2003, the World Health Assembly urged Member States (MS) to increase …
Acute cardiovascular events associated with influenza in hospitalized adults: a cross-sectional study
EJ Chow, MA Rolfes, A O'Halloran… - Annals of internal …, 2020 - acpjournals.org
Background: Influenza may contribute to the burden of acute cardiovascular events during
annual influenza epidemics. Objective: To examine acute cardiovascular events and …
annual influenza epidemics. Objective: To examine acute cardiovascular events and …
Traditional and new influenza vaccines
SS Wong, RJ Webby - Clinical microbiology reviews, 2013 - Am Soc Microbiol
The challenges in successful vaccination against influenza using conventional approaches
lie in their variable efficacy in different age populations, the antigenic variability of the …
lie in their variable efficacy in different age populations, the antigenic variability of the …
Cardiovascular implications of COVID-19 versus influenza infection: a review
Background Due to the overlapping clinical features of coronavirus disease 2019 (COVID-
19) and influenza, parallels are often drawn between the two diseases. Patients with pre …
19) and influenza, parallels are often drawn between the two diseases. Patients with pre …
Effect of high-dose trivalent vs standard-dose quadrivalent influenza vaccine on mortality or cardiopulmonary hospitalization in patients with high-risk cardiovascular …
Importance Influenza is temporally associated with cardiopulmonary morbidity and mortality
among those with cardiovascular disease who may mount a less vigorous immune response …
among those with cardiovascular disease who may mount a less vigorous immune response …